Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
<a href="https://pixabay.com/users/stevepb/">stevepb</a> / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading

New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients

The most common treatment for autoimmune conditions such as ankylosing spondylitis, plaque psoriasis, Crohn's disease, juvenile idiopathic arthritis, and rheumatoid arthritis is currently a drug called Humira, created by AbbVie.…

Continue Reading
Four New Drugs Accepted by the Scottish Medicines Consortium
<a href="https://pixabay.com/users/qimono/">qimono</a> / Pixabay

Four New Drugs Accepted by the Scottish Medicines Consortium

The Scottish Medicines Consortium, a committee that advises NHS Scotland on what medicines they should provide, has accepted four new drugs for use. These are gemtuzumab ozogamicin for acute myeloid…

Continue Reading
Drug Label Expanded in the UK for Treating Rare Inflammatory Diseases
<a href="https://pixabay.com/users/byrev/">byrev</a> / Pixabay

Drug Label Expanded in the UK for Treating Rare Inflammatory Diseases

According to a story from Hospital Healthcare Europe, The European Medicines Agency approved Kineret last year, an anti-inflammatory drug developed by Sobi. In the UK, Kineret is an approved treatment…

Continue Reading
Close Menu